Literature DB >> 33793080

Bile reflux is an independent risk factor for precancerous gastric lesions and gastric cancer: An observational cross-sectional study.

Lu Yao Zhang1, Jian Zhang1,2, Dan Li3, Yuan Liu4, Dong Ling Zhang3, Cai Fang Liu5, Na Wang1, Si Ran Wu1, Wen Quan Lu6, Jing Zhi Guo7, Yong Quan Shi1.   

Abstract

OBJECTIVE: To identify whether bile reflux on endoscopy and other related variables are risk factors for precancerous gastric lesions and gastric cancer (GC).
METHODS: A multicenter, cross-sectional and observational study was conducted in five centers in China from June to October 2019, 1162 patients were recruited and divided into the chronic gastritis (CG), the precancerous lesion (low-grade intraepithelial neoplasia and intestinal metaplasia), and GC groups (including high-grade intraepithelial neoplasia). All participants underwent detailed interviews, endoscopy and biopsy, and completed questionnaires. Odds ratio and 95% confidence interval were calculated with multivariate logistic regression models with or without adjustment for Helicobacter pylori infection.
RESULTS: We recruited 668 patients with CG, 411 with precancerous lesions and 83 with GC. By comparing the CG and precancerous lesion groups, independent risk factors for cancerous gastric lesions were the grade of bile reflux, patient's age, dietary habits and family history of GC. Similar results were obtained when comparing the CG and GC groups. In addition, bile reflux was confirmed as an independent risk factor for progression from precancerous lesions to cancer.
CONCLUSIONS: Bile reflux on endoscopy as well as age, dietary habits and a family history of GC were independent risk factors for the development of precancerous gastric lesions and GC.
© 2021 The Authors. Journal of Digestive Diseases published by Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  bile reflux; gastric neoplasms; intestinal metaplasia; precancerous lesion

Year:  2021        PMID: 33793080      PMCID: PMC8252397          DOI: 10.1111/1751-2980.12986

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


INTRODUCTION

Gastric cancer (GC) is one of the most common malignancies worldwide, ranking third for cancer‐related mortality and fifth for incidence. The development of intestinal GC has been proven to model the multistep process from normal gastric mucosa, through chronic gastritis (CG) (non‐atrophic and atrophic gastritis), intestinal metaplasia (IM) and intraepithelial neoplasia (IN), to carcinoma. IM and IN are often considered to be precancerous lesions (PCL) that, without further intervention, will turn into early GC. Patients with IM have a 6–9‐fold higher incidence of progression to GC than those with normal mucosa. , Up to 23% of the cases with low‐grade intraepithelial neoplasia (LGIN) may develop cancer while high‐grade intraepithelial neoplasia (HGIN) has a even higher rate (60%‐85%). In recent decades the mechanisms that lead to chronic inflammation and carcinoma have been explored. Helicobacter pylori (H. pylori)‐induced inflammation has been proven to be closely associated with the occurrence, development, invasion and metastasis of GC. , Eradication of H. pylori alone leads to a decrease in relative risk from 34% to 77% in the development of noncardia GC. However, further stratified analyses have demonstrated that H. pylori eradication decreased the risk of IM development but not of that of dysplasia. , This suggests that other factors may induce chronic inflammation as well, leading to GC progression. Bile reflux gastritis, also known as biliary gastritis or duodenogastric reflux, refers to the retrograde flow of bile into the stomach. Based on epidemiological studies, in vitro experiments and animal models, bile reflux is strongly associated with cardiac IM and Barrett's esophagus (BE). , , , Bile reflux is also a primary risk factor for the occurrence of remnant GC after surgery for benign diseases. However, the relationship between endoscopic bile reflux and precancerous gastric lesions and GC remains unclear. Therefore, we designed this cross‐sectional study to identify whether endoscopic bile reflux and other factors are independent risk factors for precancerous gastric lesions and GC.

PARTICIPANTS AND METHODS

Study design and population

We conducted a multicenter, cross‐sectional study among patients with upper gastrointestinal symptoms and indications for an upper endoscopy in five hospitals in China (Xijing Hospital [Xi'an, Shaanxi Province], Shaanxi Traditional Chinese Medicine Hospital [Xi'an, Shaanxi Province], the First Affiliated Hospital of Zhengzhou University [Zhengzhou, Henan Province], Affiliated Hospital of Qinghai University [Xining, Qinghai Province], and Mianyang Central Hospital [Mianyang, Sichuan Province]) from June to October, 2019. These hospitals, from four provinces in the central and western regions of China at each level of local healthcare, were selected using a convenience sampling method. The study was approved by the Ethics Committees of each participating hospital and was conducted according to the Declaration of Helsinki. Written informed consent was obtained from each participant prior to the trial registration at clinicaltrials.gov (no. NCT03976739). Participants of both sexes who met the following inclusion criteria were eligible for enrollment in the study: (a) aged between 18 and 75 years; (b) with upper gastrointestinal symptoms and indications for an upper endoscopy; (c) willing to undergo test for H. pylori diagnosis; and (d) agreed to undergo upper endoscopy and biopsy. Exclusion criteria were as follows: (a) previous upper gastrointestinal surgeries; (b) previous diagnosis of malignancy; (c) contraindications to gastroscopy and biopsy; (d) could not be interviewed due to major central nervous system disease or mental disorder, etc; (e) pregnant or lactating; and (f) those who refused to give their informed consent. All enrolled participants were further grouped according to their histopathologic reports. Biopsy specimens from cancer mass and adjacent tissues (according to the condition under the upper endoscopy) were obtained from the participants who were diagnosed with GC under endoscopy. Other participants underwent at least five biopsies as recommended by the Sydney system, including two from the greater and lesser curvature of the corpus, one from the incisura and two from the greater and lesser curvature of the antrum, respectively.

Grades of bile reflux

The bile reflux grading criteria used in the current study were consistent with the retrospective study we previously conducted.18 According to the color and status of the mucous lake under endoscopy, the grade of bile reflux was determined as follows: (a) no bile reflux, clear or no mucous lake; (b) grade I, light yellow mucous lake; (c) grade II, yellowish–green mucous lake; and (d) grade III, dark yellow, turbid and viscous mucous lake with bile patches.

Histopathological findings and diagnosis of infection

All the participants were divided into three groups based on their histopathologic results: (a) the CG group, including CG with or without atrophy; (b) the PCL group, including gastric IM and LGIN; and (c) the GC group, including HGIN and GC. Two experienced gastrointestinal pathologists who were blinded to the results of upper endoscopy and the questionnaires (as mentioned below) seperately determined and confirmed the severity of the lesion. Disagreement over the pathological results was resolved by discussion with a third pathologist. Current H. pylori infection was confirmed by a 13Curea breath test (UBT) and the technician who performed the breath test was blinded to the endoscopic finding, histopathological result and questionnaire.13,14 The current H. pylori status and history of H. pylori infection of the participants were systematically recorded.

Study questionnaire and baseline characteristics

All participants were interviewed by professional assistants in each center. The following information was obtained by a questionnaire from each participant before the endoscopic examination: their sex, age, height, bodyweight, body mass index (BMI), ethnicity, history of alcohol consumption and smoking, place of residence, education level, blood type, occupation, type of work, source of drinking water, familial history of GC, history of drug use (especially nonsteroidal anti‐inflammatory drugs [NSAIDs]), H. pylori infection status, dietary habits (high‐salt diet, leftover dishes, fried, preserved, spicy or smoked food, fresh fruits and fresh vegetables), and habits of tea and coffee drinking.

Statistical analysis

All the statistical analysis were performed by using the SPSS Statistics 23.0 (IBM, Armonk, NY). Continuous variables were expressed as mean ± standard deviation, while categorical variables were expressed as numbers and percentages or frequencies. The comparison of differences was performed using the Student's t‐test or one‐way ANOVA for continuous variables, and using the Fisher's exact test or χ2 test for categorical variables. A multivariate logistic regression model was used to calculate the odds ratio (OR) and their 95% confidence interval (CI) to estimate the relationship between bile reflux and precancerous gastric lesions or GC and, to identify the associated independent risk factors. Variables that were statistically significant in the univariate analysis as well as those had been reported to have an impact on the occurrence and development of GC were included in the multivariate analysis. Three single multivariable models were used to compare the independent risk factors between each of the two groups. To analyze the risk factors related to different types of PCL we compared IM, LGIN and HGIN with CG. A two‐tailed P value of less than 0.05 was considered statistically significant.

RESULTS

Baseline characteristics of the participants

From June 2019 to October 2019 a total of 1162 patients were recruited from the Endoscopic Center of the five hospitals. GC was detected in 7.1% (n = 83) of all participants, and 35.4% (n = 411) were diagnosed with PCL. Baseline characteristics of the participants in the three groups are summarized in Table 1. The PCL and GC groups were significantly older than the CG group. Most participants with PLC and GC were men (both P < 0 .001), while the proportion of men and women was comparable in the CG group. The GC group had a lower BMI (21.8 ± 3.3 kg/m2) than the PCL (23.0 ± 3.8 kg/m2) and CG (22.7 ± 3.6 kg/m2) groups (P = 0.029). In addition, the PCL and GC groups were more likely to report a family history of GC was higher in the PCL and GC groups than the CG group (16.1% and 18.1% vs 8.7%), and most participants with GC were rural residents and had a lower educational level (all P < 0.001). Although there were no statistically significant differences in ethnicity, blood type or H. pylori infection status among the three groups, obvious differences in smoking and alcohol status, water source and detection rate of bile reflux were observed.
TABLE 1

Baseline characteristics of the participants among the chronic gastritis (CG), precancerous lesion (PCL), and the gastric cancer (GC) groups

CG (n = 668)PCL (n = 411)GC (n = 83) P value
Age, y (mean ± SD)47.2 ± 12.552.5 ± 9.7a 59.5 ± 10.1a,b <0.001
Sex, n (%)<0.001
Male332 (49.7)245 (59.6)a 56 (67.5)a
Female336 (50.3)166 (40.4)27 (32.5)
Ethnicity, n (%)0.085
Han617 (92.4)393 (95.6)76 (91.6)
Others51 (7.6)18 (4.4)7 (8.4)
BMI, kg/m2 (mean ± SD)22.7 ± 3.623.0 ± 3.821.8 ± 3.3a,b 0.029
Residence, n (%)<0.001
Urban387 (57.9)249 (60.6)24 (28.9)a,b
Town98 (14.7)57 (13.9)12 (14.5)
Rural183 (27.4)105 (25.5)47 (56.6)a,b
Education level, n (%)<0.001
High (bachelor's degree or above)259 (38.8)122 (29.7)a 6 (7.2)a,b
Low (below bachelor's degree)409 (61.2)289 (70.3)a 77 (92.8)a,b
Smoking, n (%)<0.001
Current smoker144 (21.5)110 (26.8)34 (41.0)a,b
Former smoker58 (8.7)56 (13.6)a 12 (14.5)a,b
Never466 (69.8)245 (59.6)a 37 (44.6)a,b
Alcohol consumption, n (%)0.018
Current drinker100 (15.0)65 (15.8)13 (15.7)
Former drinker51 (7.6)50 (12.2)a 2 (2.4)
Never517 (77.4)296 (72.0)a 68 (81.9)b
Water source, n (%)<0.001
Tap water597 (89.4)332 (80.8)a 55 (66.3)a,b
Well water61 (9.1)56 (13.6)a 25 (30.1)a,b
River and lake10 (1.5)23 (5.6)a 3 (3.6)
Family history of GC, n (%)58 (8.7)66 (16.1)a 15 (18.1)a <0.001
History of drug use, n (%)
NSAIDs8 (1.2)3 (0.7)2 (2.4)0.246
Metformin16 (2.4)11 (2.7)2 (2.4)0.958
Statin3 (0.4)5 (1.2)1 (1.2)0.643
Diet (usually: >thrice/wk), n (%)
High‐salt diet156 (23.4)113 (27.5)36 (43.4)a,b <0.001
Leftover dishes211 (31.6)185 (45.0)a 50 (60.2)a,b <0.001
Fried food195 (29.2)119 (29.0)37 (44.6)a,b 0.013
Pickled food168 (25.1)140 (34.1)a 46 (55.4)a,b <0.001
Spicy food340 (50.9)202 (49.1)64 (77.1)a,b <0.001
Smoke‐dried food76 (11.4)42 (10.2)3 (3.6)0.077
Fresh vegetable consumption (>100 g/d)155 (23.2)128 (31.1)a 17 (20.5)0.01
Fresh fruit consumption (>100 g/d)218 (32.6)160 (38.9)a 31 (37.3)0.102
Beverage, n (%)
Tea206 (30.8)114 (27.7)30 (36.1)0.259
Coffee23 (3.4)9 (2.2)1 (1.2)0.314
Blood type, n (%)0.147
A81 (12.1)59 (14.4)6 (7.2)
B112 (16.8)57 (13.9)7 (8.4)
O109 (16.3)79 (19.2)17 (20.5)
AB45 (6.7)33 (8.0)5 (6.0)
Unknown/missing321 (48.1)183 (44.5)48 (57.8)
H. pylori status, n (%)0.759
Current infection234 (35.0)136 (33.1)25 (30.1)
Former infection110 (16.5)63 (15.3)16 (19.3)
Never infected324 (48.5)212 (51.6)42 (50.6)
Bile reflux, n (%)<0.001
No469 (70.2)246 (59.9)39 (47.0)
Yes199 (29.8)165 (40.1)a 44 (53.0)a,b
Grade I104 (15.6)72 (17.5)21 (25.3)a
Grade II69 (10.3)61 (14.8)a 12 (14.5)
Grade III26 (3.9)32 (7.8)a 11 (13.3)a

Note: P < 0.05 compared with the CG group,a or with the PCL group.b

The CG group includes non‐atrophic gastritis and chronic atrophic gastritis. The PCL group includes gastric intestinal metaplasia and mild‐to‐moderate dysplasia. And the GC group includes severe intraepithelial neoplasia and gastric cancer.

Abbreviations: BMI, body mass index; H. pylori, Helicobacter pylori; NSAIDs, nonsteroidal anti‐inflammatory drugs; SD, standard deviation.

Baseline characteristics of the participants among the chronic gastritis (CG), precancerous lesion (PCL), and the gastric cancer (GC) groups Note: P < 0.05 compared with the CG group,a or with the PCL group.b The CG group includes non‐atrophic gastritis and chronic atrophic gastritis. The PCL group includes gastric intestinal metaplasia and mild‐to‐moderate dysplasia. And the GC group includes severe intraepithelial neoplasia and gastric cancer. Abbreviations: BMI, body mass index; H. pylori, Helicobacter pylori; NSAIDs, nonsteroidal anti‐inflammatory drugs; SD, standard deviation. The PCL group included 379 patients with IM and 32 with LGIN. We compared the factors between the two subgroups, as shown in Table S1. There were more smokers and alcohol drinkers in the LGIN subgroup, while other factors remained insignificant.

Multivariate analysis

Multivariate logistic regression analysis showed that participant's age, history of smoking, drinking of non‐tap water, a family history of GC, and a high‐salt diet, consumption of pickled food and bile reflux were independent risk factors for PCL and GC. OR and 95% CI with and without H. pylori adjustment are presented in Table S2. Based on the the multivariate logistic regression analysis three multivariate analysis models were conducted to compare the difference in variables between each pair of the groups among all three groups. As shown in Table 2, we compared the 668 patients in the CG group and 411 patients in the PCL group using multivariate logistic regression. The results demonstrated independent hazard associations of age, sex, water source, family history of GC, overnight consumption of dishes, pickled food and bile reflux grade with PCL, with or without adjustment for H. pylori. Moreover, an increasing OR were observed with a higher grade of bile reflux. However, sufficient consumption of fresh vegetables and fruits (adjusted OR 0.58 and 0.65, respectively) was observed to be relatively protective against PCL.
TABLE 2

Multivariate logistic regression analysis model comparing the chronic gastritis group and the precancerous lesion group

Multivariate analysis
Univariate analysisUnadjusted H. pylori‐adjusted
OR (95% CI) P valueOR (95% CI) P valueOR (95% CI) P value
Age1.04 (1.03–1.05)<0.051.05 (1.03–1.06)<0.051.05 (1.03–1.06)<0.05
Sex (ref: female)1.49 (1.17–1.92)<0.0011.65 (1.15–2.37)<0.0011.67 (1.16–2.39)<0.001
BMI1.02 (0.99–1.05)>0.051.03 (0.99–1.07)>0.051.03 (0.99–1.07)>0.05
Education level (ref: high)1.50 (1.15–1.95)<0.051.07 (0.79–1.45)>0.051.08 (0.79–1.47)>0.05
Smoking status (ref: never)
Current smoker1.45 (1.09–1.95)<0.051.10 (0.74–1.54)>0.051.11 (0.75–1.65)>0.05
Former smoker1.84 (1.22–2.74)<0.051.19 (0.71–1.99)>0.051.18 (0.70–1.98)>0.05
Alcohol status (ref: never)
Current drinker1.14 (0.81–1.60)>0.050.97 (0.63–1.48)>0.050.96 (0.63–1.47)>0.05
Former drinker1.71 (1.13–2.59)<0.051.28 (0.76–2.13)>0.051.26 (0.76–2.12)>0.05
Water source (ref: tap)
Well1.65 (1.12–2.43)<0.051.28 (0.84–1.95)>0.051.26 (0.82–1.93)>0.05
River and lake4.14(1.95–8.79)<0.0014.03 (1.82–8.90)<0.0014.19 (1.89–9.31)<0.001
Family history of GC (ref: no)2.01 (1.38–2.93)<0.0011.99 (1.33–2.98)<0.0012.01 (1.34–3.02)<0.001
Leftover dishes (ref: no)1.77 (1.38–2.29)<0.051.40 (1.04–1.87)<0.051.41 (1.05–1.88)<0.05
Pickled food (ref: no)1.54 (1.18–2.01)<0.051.19 (0.88–1.62)>0.051.20 (0.89–1.63)>0.05
Fresh vegetable consumption (ref: <100 g/d)1.48 (1.13–1.96)<0.050.59 (0.43–0.79)<0.050.58 (0.43–0.79)<0.05
Fresh fruit consumption (ref: <100 g/d)1.10 (1.01–1.19)<0.050.67 (0.50–0.88)<0.050.65 (0.49–0.87)<0.05
Grade of bile reflux (ref: no)
I1.32 (0.94–1.85)<0.0011.61 (1.11–2.32)<0.0011.61 (1.12–2.33)<0.001
II1.69 (1.16–2.46)<0.0012.07 (1.37–3.13)<0.0012.05 (1.36–3.11)<0.001
III2.35 (1.37–4.03)<0.0012.84 (1.55–5.20)<0.0012.79 (1.52–5.11)<0.001

Abbreviations: BMI, body mass index; CI, confidence interval; GC, gastric cancer; H. pylori, Helicobacter pylori; OR, odds ratio.

Multivariate logistic regression analysis model comparing the chronic gastritis group and the precancerous lesion group Abbreviations: BMI, body mass index; CI, confidence interval; GC, gastric cancer; H. pylori, Helicobacter pylori; OR, odds ratio. Another logistic regression model was performed to compare the CG and the GC groups to determine the independent risk factors for GC. As shown in Table 3, age (adjusted OR 1.10), education level (adjusted OR 3.01), residence (rural: adjusted OR 1.94), a family history of GC (adjusted OR 3.08), consumption of a high‐salt diet (adjusted OR 2.42), spicy food (adjusted OR 3.15) and the presence of bile reflux (adjusted OR 1.94) were found to be independent risk factors for GC when compared with relatively mild lesions.
TABLE 3

Multivariate logistic regression analysis model comparing the chronic gastritis group and the gastric cancer (GC) group

Multivariate analysis
Univariate analysisUnadjusted H. pylori‐adjusted
OR (95% CI) P valueOR (95% CI) P valueOR (95% CI) P value
Age1.10 (1.08–1.13)<0.0011.10 (1.07–1.13)<0.0011.10 (1.07–1.13)<0.001
Sex (ref: female)2.10 (1.29–3.41)0.0141.81 (0.79–4.13)>0.051.92 (0.84–4.41)>0.05
BMI0.93 (0.86–0.99)0.0410.92 (0.84–1.01)>0.050.92 (0.85–1.01)>0.05
Education level (ref: high)8.13 (3.49–18.92)<0.0012.91 (1.14–7.46)<0.0013.01 (1.17–7.76)<0.001
Residence (ref: urban)
Town1.97 (0.95–4.09)>0.051.38 (0.57–3.38)>0.051.35 (0.55–3.31)>0.05
Rural4.14 (2.46–6.98)<0.0011.90 (0.99–3.64)>0.051.94 (1.01–3.74)<0.05
History of smoking (ref: never)2.87 (1.81–4.56)<0.0012.03 (0.90–4.62)>0.051.97 (0.87–4.47)>0.05
History of alcohol consumption (ref: never)0.755 (0.42–1.36)>0.050.72 (0.32–1.60)>0.050.69 (0.31–1.54)>0.05
Water source (ref: tap water)
Non‐tap water1.57 (0.82–3.03)>0.050.96 (0.18–5.01)>0.050.89 (0.17–4.60)>0.05
Family history of GC (ref: no)2.32 (1.25–4.32)<0.0012.88 (1.30–6.38)<0.0013.08 (1.38–6.87)<0.001
High‐salt diet (ref: no)2.51 (1.57–4.02)<0.0012.35 (1.31–4.24)<0.0012.42 (1.33–4.38)<0.001
Leftover dishes (ref: no)3.28 (2.05–5.25)<0.0011.35 (0.74–2.45)>0.051.41 (0.77–2.59)>0.05
Fried food (ref: no)1.95 (1.23–3.10)<0.051.31 (0.70–2.47)>0.051.37 (0.72–2.58)>0.05
Pickled food (ref: no)3.70 (2.32–5.90)<0.0011.21 (0.65–2.25)>0.051.19 (0.64–2.21)>0.05
Spicy food (ref: no)3.25 (1.91–5.54)<0.0013.12 (1.65–5.93)<0.0013.15 (1.65–5.99)<0.001
Bile reflux (ref: no)2.659 (1.68–4.22)<0.0011.91 (1.08–3.40)<0.0011.94 (1.09–3.46)<0.001

Abbreviations: BMI, body mass index; CI, confidence interval; H. pylori, Helicobacter pylori; OR, odds ratio.

Multivariate logistic regression analysis model comparing the chronic gastritis group and the gastric cancer (GC) group Abbreviations: BMI, body mass index; CI, confidence interval; H. pylori, Helicobacter pylori; OR, odds ratio. We further used a logistic regression model to determine whether any factor plays a role in the progression from the severe mucosal lesion to the final stage of carcinoma, and found that age (adjusted OR 1.08), residence (rural: adjusted OR 2.62), over‐consumption of spicy food (adjusted OR 3.10) and bile reflux (adjusted OR 1.75) were independent risk factors for GC (Table 4).
TABLE 4

Multivariate logistic regression analysis model comparing the precancerous lesion group and the gastric cancer (GC) group

Multivariate analysis
Univariate analysisUnadjusted H. pylori‐adjusted
OR (95% CI) P valueOR (95% CI) P valueOR (95% CI) P value
Age1.08 (1.05–1.11)<0.051.08 (1.04–1.11)<0.051.08 (1.04–1.11)<0.05
Sex (ref: female)1.41 (0.85–2.32)>0.051.40 (0.64–3.09)>0.051.37 (0.62–3.03)>0.05
BMI0.91 (0.85–098)<0.050.93 (0.85–1.01)>0.050.93 (0.85,1.01)>0.05
Education level (ref: high)5.42 (2.30–12.77)<0.052.22 (0.85–5.25)>0.052.28 (0.87–5.98)>0.05
Residence (ref: urban)
Town2.36 (1.10–5.05)<0.051.69 (0.71–4.00)>0.051.68 (0.71–4.00)>0.05
Rural5.03 (2.88–8.76)<0.052.62 (1.31–5.25)<0.052.62 (1.31–5.24)<0.05
History of smoking (ref: never)1.84 (1.14–2.95)<0.051.37 (0.63–2.99)>0.051.43 (0.65–3.14)>0.05
History of alcohol consumption (ref: never)0.57 (0.31–1.03)>0.050.50 (0.24–1.06)>0.050.49 (0.23–1.05)>0.05
Water source (ref: tap water)
Non‐tap water2.14 (1.28–3.59)<0.051.25 (0.63–2.45)>0.051.24 (0.63–2.44)>0.0
Family history of GC (ref: no)1.15 (0.62–2.14)>0.051.55 (0.75–3.21)>0.051.55 (0.74–3.22)>0.05
High‐salt diet (ref: No)2.02 (1.24–3.28)<0.051.25 (0.70–2.21)>0.051.22 (0.69–2.18)>0.05
Leftover dishes (ref: no)1.85 (1.15–2.99)<0.050.86 (0.47–1.56)>0.050.85 (0.47–1.56)>0.05
Fried food (ref: no)1.97 (1.22–3.21)<0.050.80 (0.44–1.48)>0.050.80 (0.43–1.48)>0.05
Pickled food (ref: no)2.41 (1.49–3.88)<0.051.42 (0.78–2.61)>0.051.42 (0.77–2.60)>0.05
Spicy food (ref: no)3.49 (2.02,6.03)<0.0013.12 (1.63–5.98)<0.0013.10 (1.61–5.93)<0.001
Bile reflux (ref: no)1.68 (1.05–2.70)<0.0011.76 (1.02–3.03)<0.0011.75 (1.01–3.01)<0.001

Abbreviations: BMI, body mass index; CI, confidence interval; H. pylori, Helicobacter pylori; OR, odds ratio.

Multivariate logistic regression analysis model comparing the precancerous lesion group and the gastric cancer (GC) group Abbreviations: BMI, body mass index; CI, confidence interval; H. pylori, Helicobacter pylori; OR, odds ratio.

DISCUSSION

The results of our study reveal the factors that may have a strong association with the development and progression of precancerous gastric lesions and GC. Our study was a cross‐sectional study conducted at multiple centers and a detailed questionnaire was designed to collect comprehensive demographic information and dietary habits of the participants. All of the participants we recruited underwent upper endoscopy and mapping biopsies. Through systematic analysis, we assessed the factors that might be associated with PCL, and identified those that might influence the progression from precancerous conditions to carcinoma. To the best of our knowledge this was the first time that bile reflux was confirmed as an independent factor associated with precancerous gastric lesions and GC. The explanation for these observations derives from two phenomena: (a) the incidence of primary bile reflux has been gradually increasing during the past few decades; and (b) the influence of primary bile reflux remains unclear, which results in its neglect by gastroenterologists, endoscopists and pathologists. However, it may play a crucial role in the progression from normal gastric mucosa through PCL to GC in the absence of H. pylori infection. A positive link between bile reflux and a subsequent elevated risk of IM and GC development has been consistently reported by two Japanese clinical studies. , A number of experiments have demonstrated the underlying mechanisms by which bile acid contributes to the progression of GC and PCL. First, hydrophobic bile acids such as chenodeoxycholic acid can cause increased cellular invasion of gastric cells through the activation of PKC and COX‐2 induction. In addition, the bile acid receptor TGR5 plays a role in promoting the epithelial–mesenchymal transition of GC cells. Our group has previously demonstrated that the miR‐92a‐1‐5p/FOXD1/NF‐κB/CDX2 regulatory axis plays a crucial role in the development of IM caused by bile acid. As a result, more attention should be paid to bile reflux during endoscopy. In the present study we found that a family history of GC may be an important factor linked to the occurrence of precancerous gastric lesions and GC, with OR reaching 2 to 3, which is consistent with the results of previous epidemiological trials. Previous studies have reported that a family history of any precancerous changes and GC presented a 2.5‐fold and a 3.8‐fold hazard, respectively, of noncardia GC compared with index people who had relatives with mild mucosal changes. Recently, researchers found that individuals with a family history of GC were at a high risk of IN or dysplasia. In addition, such patients were more likely to progress from PCL to GC. This suggests that a family history of GC is a significant risk factor for the development of GC and the progression of PCL to GC. Therefore, when screening for GC close attention should be paid to the family history of GC. Moreover, some specific dietary factors seem to be associated with the development of malignant mucosal lesions. In our study, high‐salt diet and an excess of spicy food may be important dietary factors related to the occurrencce of GC, whereas fresh vegetables and fruits may play a protective role. Several trials focused on the impact of routine dietary intake on GC have made similar observations, and high‐salt intake has been reported to be associated with an increased risk of atrophic gastritis with IM. The results of a 10‐year epidemiological study of GC also demonstrated that a high‐salt, high‐fat and spicy diet was a significant factor for GC in both female and male participants. A high‐salt diet can lead to damage and a persistent inflammatory state of the gastric mucosa and increase the incidence of endogenous mutations. It is also thought to contribute to the colonization by H. pylori, and to have a synergistic effect between salt intake and H. pylori infection in the development of GC. , Although current and previous studies suggest that a high intake of spicy food may be associated with an increased incidence of cancer this view remains controversial. This association may be related to different populations, regions, living habits and environmental factors. Our results are in accordance with the notion that a familial aggregation of GC and gastric precancerous changes could be due to a genetic or inherited predisposition and exposure to similar environmental factors, such as carcinogenic H. pylori strains (if any), common dietary habits or other carcinogenic exposures, within a family. Unexpectedly, our study was unable to demonstrate a statistical association between H. pylori status and both premalignant lesions and GC, which conflicts with what is well known according to public consensus and what has been reported in earlier trials. We further reviewed some participants to determine the underlying reason. Owing to the increasing awareness of H. pylori infection, a proportion of participants from the CG group asked for a gastroscopy after knowing their H. pylori infection status. Interestingly, discriminatory differences in the distribution of educational level and residence were demonstrated in the present study. The proportion of participants with a low education level and residence in the rural area was much higher in the GC group than in the other two groups and this result was in line with a national epidemiological report in 2015, and may be explained by the lack of H. pylori eradication treatment and regular endoscopic surveillance in these participants. In addition, there is a strong association between drinking unchlorinated water from wells and surface water sources and the risk of GC. The development of GC is a complex pathological process with multifactorial involvement and multiple steps. Our results found discriminatory associations with older age, consumption of spicy food and bile acid for precancerous gastric conditions and similar associations were also presented through comparisons with the GC group. When comparing the PCL group with the GC group, the abovementioned risk factors still showed elevated OR, which also indicates that the occurrence of GC is the result of a continuous effect of each risk factor. A previous cross‐sectional study performed in a U.S. population reported strong associations of older age, male sex, nonwhite race or ethnicity, and current smoking with gastric IM as well as atrophic gastritis. However, this study was derived from a U.S. veteran cohort with an imbalanced sex and racial distribution and was unable to collect important relevant information, such as previous H. pylori infection and routine diet, and particularly the grade of bile reflux. A discriminatory strength of our study is that we enrolled participants who were diagnosed with all histological types of gastric mucosa lesions, including GC. Primary bile reflux, which occurs without gastric surgery, is associated with gallbladder dysfunction and gastric or duodenal motility disorders. The results of our previous retrospective study showed that bile reflux was associated with age, sex and duration of fasting, and there have been no reports of bile reflux being associated with other factors, such as water source, family history of GC, a high‐salt diet, spicy food and place of residence. Therefore, we identified bile reflux as one of the independent risk factors for GC and PCL. There were some limitations to the present study. First, all the participants were recruited from endoscopy centers in hospitals, which implies that the participants we enrolled were symptomatic with an indication for upper endoscopy; thus, minimal selection bias was inevitable and a higher prevalence of PCL and GC than average was observed in our study. Our study was also limited by the characteristics of cross‐sectional studies. Accordingly, we were unable to observe prospectively the deterioration or improvement of participants with different stages of mucosa lesions, and an observational follow‐up study that requires regular surveillance for participants is necessary to construct a predictive model for risk stratification. Additionally, long‐term multicenter clinical trials should be performed to identify the role of bile reflux in the whole progression from normal mucosa to gastric malignancy. Although we have described the minor difference between subgroups of the precancerous group, owing to the unsatisfactory proportion of the two subgroups (IM: LGIN = 10:1), the results we obtained were relatively unconvincing. In conclusion, bile reflux under endoscopy, age, family history of GC and some specific dietary habits are independent risk factors for the occurrence of precancerous gastric lesions and GC.

CONFLICT OF INTEREST

The authors declare that they have no conflict of interest. Table S1. Baseline data and characteristics of the precancerous gastric lesions group. Click here for additional data file. Table S2. Multivariate logistic regression analysis model comparing the chronic gastritis, the precancerous lesion and the gastric cancer groups. Click here for additional data file.
  36 in total

Review 1.  New Causes for the Old Problem of Bile Reflux Gastritis.

Authors:  Marshall E McCabe; Christen K Dilly
Journal:  Clin Gastroenterol Hepatol       Date:  2018-03-02       Impact factor: 11.382

2.  Clinical epidemiology of gastric cancer in Hehuang valley of China: a 10-year epidemiological study of gastric cancer.

Authors:  Su Yan; Bin Li; Zhen-Zhong Bai; Jun-Qi Wu; Da-Wei Xie; Ying-Cai Ma; Xu-Xiang Ma; Jun-Hui Zhao; Xin-Jian Guo
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

3.  Bile acid promotes intestinal metaplasia and gastric carcinogenesis.

Authors:  Masana Tatsugami; Masanori Ito; Shinji Tanaka; Masaharu Yoshihara; Hirofumi Matsui; Ken Haruma; Kazuaki Chayama
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-09-25       Impact factor: 4.254

Review 4.  Surveillance of patients with gastric precancerous conditions.

Authors:  Jorge Lage; Noriya Uedo; Mário Dinis-Ribeiro; Kenshi Yao
Journal:  Best Pract Res Clin Gastroenterol       Date:  2016-09-14       Impact factor: 3.043

Review 5.  Helicobacter pylori-induced gastric inflammation and gastric cancer.

Authors:  Fei Wang; Wenbo Meng; Bingyuan Wang; Liang Qiao
Journal:  Cancer Lett       Date:  2013-08-24       Impact factor: 8.679

6.  A model for gastric cancer epidemiology.

Authors:  P Correa; W Haenszel; C Cuello; S Tannenbaum; M Archer
Journal:  Lancet       Date:  1975-07-12       Impact factor: 79.321

7.  Evaluation of the Epidemiologic Efficacy of Eradicating Helicobacter pylori on Development of Gastric Cancer.

Authors:  Fujiao Duan; Chunhua Song; Jintao Zhang; Peng Wang; Hua Ye; Liping Dai; Jianying Zhang; Kaijuan Wang
Journal:  Epidemiol Rev       Date:  2019-01-31       Impact factor: 6.222

8.  Relation between bile acid reflux into the stomach and the risk of atrophic gastritis and intestinal metaplasia: a multicenter study of 2283 cases.

Authors:  Takeshi Matsuhisa; Tetsuo Arakawa; Tetsuo Watanabe; Tadashi Tokutomi; Kouichi Sakurai; Seisuke Okamura; Shinji Chono; Tomoari Kamada; Atsushi Sugiyama; Yoshinori Fujimura; Kenji Matsuzawa; Masanori Ito; Mitsugu Yasuda; Hiroyoshi Ota; Ken Haruma
Journal:  Dig Endosc       Date:  2013-01-29       Impact factor: 7.559

9.  Cause and effect between concentration-dependent tissue damage and temporary cell proliferation in rat stomach mucosa by NaCl, a stomach tumor promoter.

Authors:  C Furihata; H Ohta; T Katsuyama
Journal:  Carcinogenesis       Date:  1996-03       Impact factor: 4.944

10.  The role of bile acids in cellular invasiveness of gastric cancer.

Authors:  Yu-Chung Wu; Chang-Fang Chiu; Chung-Tzu Hsueh; Chung-Tsen Hsueh
Journal:  Cancer Cell Int       Date:  2018-05-21       Impact factor: 5.722

View more
  4 in total

1.  Bile reflux is an independent risk factor for precancerous gastric lesions and gastric cancer: An observational cross-sectional study.

Authors:  Lu Yao Zhang; Jian Zhang; Dan Li; Yuan Liu; Dong Ling Zhang; Cai Fang Liu; Na Wang; Si Ran Wu; Wen Quan Lu; Jing Zhi Guo; Yong Quan Shi
Journal:  J Dig Dis       Date:  2021-05-06       Impact factor: 2.325

Review 2.  Roles and action mechanisms of bile acid-induced gastric intestinal metaplasia: a review.

Authors:  Qijin He; Limin Liu; Jingge Wei; Jiaying Jiang; Zheng Rong; Xin Chen; Jingwen Zhao; Kui Jiang
Journal:  Cell Death Discov       Date:  2022-04-04

3.  Bile Acid-Microbiome Interaction Promotes Gastric Carcinogenesis.

Authors:  Shouli Wang; Junliang Kuang; Hongwei Zhang; Wenlian Chen; Xiaojiao Zheng; Jieyi Wang; Fengjie Huang; Kun Ge; Mengci Li; Mingliang Zhao; Cynthia Rajani; Jinshui Zhu; Aihua Zhao; Wei Jia
Journal:  Adv Sci (Weinh)       Date:  2022-03-14       Impact factor: 17.521

Review 4.  Bile Reflux Gastritis: Insights into Pathogenesis, Relevant Factors, Carcinomatous Risk, Diagnosis, and Management.

Authors:  Xiaolan Shi; Zijiao Chen; Yi Yang; Su Yan
Journal:  Gastroenterol Res Pract       Date:  2022-09-12       Impact factor: 1.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.